{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:27:41Z","timestamp":1784366861754,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100872"],"award-info":[{"award-number":["82100872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"High-level Personnel Research Start-up Funding of Fujian medical university","award":["XRCZX2020003"],"award-info":[{"award-number":["XRCZX2020003"]}]},{"name":"Scientific Research Project of Fujian Education Department","award":["JAT190175"],"award-info":[{"award-number":["JAT190175"]}]},{"name":"Joint Funds for Innovation of Science and Technology of Fujian province","award":["2019Y9062"],"award-info":[{"award-number":["2019Y9062"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2020J011012"],"award-info":[{"award-number":["2020J011012"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s40264-022-01210-2","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T04:02:31Z","timestamp":1658289751000},"page":"951-959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Anti-tumor Necrosis Factor-Alpha Therapy and Hypoglycemia: A Real-World Pharmacovigilance Analysis"],"prefix":"10.1007","volume":"45","author":[{"given":"Yu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhuo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"issue":"3","key":"1210_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","volume":"119","author":"BB Aggarwal","year":"2012","unstructured":"Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood. 2012;119(3):651\u201365. https:\/\/doi.org\/10.1182\/blood-2011-04-325225.","journal-title":"Blood"},{"issue":"6","key":"1210_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/apt.15097","volume":"49","author":"UN Shivaji","year":"2019","unstructured":"Shivaji UN, Sharratt CL, Thomas T, Smith SCL, Iacucci M, Moran GW, et al. Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2019;49(6):664\u201380. https:\/\/doi.org\/10.1111\/apt.15097.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1210_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00296-020-04666-6","volume":"41","author":"IAM van den Oever","year":"2021","unstructured":"van den Oever IAM, Baniaamam M, Simsek S, Raterman HG, van Denderen JC, van Eijk IC, et al. The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis. Rheumatol Int. 2021;41(2):319\u201328. https:\/\/doi.org\/10.1007\/s00296-020-04666-6.","journal-title":"Rheumatol Int"},{"issue":"1","key":"1210_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13075-015-0559-8","volume":"17","author":"DY Chen","year":"2015","unstructured":"Chen DY, Chen YM, Hsieh TY, Hsieh CW, Lin CC, Lan JL. Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis. Arthritis Res Ther. 2015;17(1):52. https:\/\/doi.org\/10.1186\/s13075-015-0559-8.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1210_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4239\/wjd.v12.i3.238","volume":"12","author":"CR Wang","year":"2021","unstructured":"Wang CR, Tsai HW. Anti- and non-tumor necrosis factor-\u03b1-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. World J Diabetes. 2021;12(3):238\u201360. https:\/\/doi.org\/10.4239\/wjd.v12.i3.238.","journal-title":"World J Diabetes"},{"issue":"7","key":"1210_CR6","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/jdv.12814","volume":"29","author":"T Pina","year":"2015","unstructured":"Pina T, Armesto S, Lopez-Mejias R, Genre F, Ubilla B, Gonzalez-Lopez MA, et al. Anti-TNF-\u03b1 therapy improves insulin sensitivity in non-diabetic patients with psoriasis: a 6-month prospective study. J Eur Acad Dermatol Venereol JEADV. 2015;29(7):1325\u201330. https:\/\/doi.org\/10.1111\/jdv.12814.","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"1","key":"1210_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jcb.26174","volume":"119","author":"MSH Akash","year":"2018","unstructured":"Akash MSH, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2018;119(1):105\u201310. https:\/\/doi.org\/10.1002\/jcb.26174.","journal-title":"J Cell Biochem"},{"key":"1210_CR8","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2022.8460\/2021","author":"L Zabalza","year":"2022","unstructured":"Zabalza L, de Carlos J, Ezcurra I, Rull\u00e1n M, Elosua A, Rubio S, et al. Infliximab-induced hypoglycemia, a rare but relevant side effect. Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva. 2022. https:\/\/doi.org\/10.17235\/reed.2022.8460\/2021.","journal-title":"Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva."},{"issue":"11","key":"1210_CR9","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/imj.14636","volume":"49","author":"JY Mah","year":"2019","unstructured":"Mah JY, Teng J, Gilfillan C. Tumour necrosis factor-alpha inhibitor induced recurrent symptomatic hypoglycaemia. Intern Med J. 2019;49(11):1460\u20131. https:\/\/doi.org\/10.1111\/imj.14636.","journal-title":"Intern Med J"},{"key":"1210_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1752-1947-6-5","volume":"6","author":"JB Czajkowska","year":"2012","unstructured":"Czajkowska JB, Shutty B, Zito S. Development of low blood glucose readings in nine non-diabetic patients treated with tumor necrosis factor-alpha inhibitors: a case series. J Med Case Reports. 2012;6:5. https:\/\/doi.org\/10.1186\/1752-1947-6-5.","journal-title":"J Med Case Reports"},{"issue":"1","key":"1210_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/rheumatology\/kel322","volume":"46","author":"JG Boulton","year":"2007","unstructured":"Boulton JG, Bourne JT. Unstable diabetes in a patient receiving anti-TNF-alpha for rheumatoid arthritis. Rheumatology (Oxford). 2007;46(1):178\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/kel322.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1210_CR12","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaad.2008.12.012","volume":"60","author":"D Cheung","year":"2009","unstructured":"Cheung D, Bryer-Ash M. Persistent hypoglycemia in a patient with diabetes taking etanercept for the treatment of psoriasis. J Am Acad Dermatol. 2009;60(6):1032\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2008.12.012.","journal-title":"J Am Acad Dermatol"},{"issue":"15","key":"1210_CR13","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2009.460","volume":"301","author":"RA Whitmer","year":"2009","unstructured":"Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301(15):1565\u201372. https:\/\/doi.org\/10.1001\/jama.2009.460.","journal-title":"JAMA"},{"issue":"5","key":"1210_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s2213-8587(18)30315-2","volume":"7","author":"SA Amiel","year":"2019","unstructured":"Amiel SA, Aschner P, Childs B, Cryer PE, de Galan BE, Frier BM, Gonder-Frederick L, Heller SR, Jones T, Khunti K, Leiter LA, Luo Y, McCrimmon RJ, Pedersen-Bjergaard U, Seaquist ER, Zoungas S. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019;7(5):385\u201396. https:\/\/doi.org\/10.1016\/s2213-8587(18)30315-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"1210_CR15","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1007\/s00125-019-4964-4","volume":"62","author":"M Nilsson","year":"2019","unstructured":"Nilsson M, Jensen N, Gejl M, Bergmann ML, Storgaard H, Zander M, et al. Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial. Diabetologia. 2019;62(10):1948\u201358. https:\/\/doi.org\/10.1007\/s00125-019-4964-4.","journal-title":"Diabetologia"},{"issue":"9","key":"1210_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s40264-021-01091-x","volume":"44","author":"E Rocca","year":"2021","unstructured":"Rocca E, Gauffin O, Savage R, Vidlin SH, Grundmark B. Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020. Drug Saf. 2021;44(9):987\u201398. https:\/\/doi.org\/10.1007\/s40264-021-01091-x.","journal-title":"Drug Saf"},{"issue":"6","key":"1210_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s40257-021-00625-4","volume":"22","author":"PM Jedlowski","year":"2021","unstructured":"Jedlowski PM, Jedlowski MF, Fazel MT. DPP-4 inhibitors and increased reporting odds of bullous pemphigoid: a pharmacovigilance study of the FDA adverse event reporting system (FAERS) from 2006 to 2020. Am J Clin Dermatol. 2021;22(6):891\u2013900. https:\/\/doi.org\/10.1007\/s40257-021-00625-4.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"1210_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s40257-021-00645-0","volume":"23","author":"E Raschi","year":"2022","unstructured":"Raschi E, Fusaroli M, La Placa M, Ardizzoni A, Zamagni C, Poluzzi E, et al. Skin toxicities with cyclin-dependent kinase 4\/6 inhibitors in breast cancer: signals from disproportionality analysis of the FDA adverse event reporting system. Am J Clin Dermatol. 2022;23(2):247\u201355. https:\/\/doi.org\/10.1007\/s40257-021-00645-0.","journal-title":"Am J Clin Dermatol"},{"key":"1210_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14660","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Xie W, Zheng C, Liu L, Chen Z, Wang X. Hypoglycemia associated with direct-acting anti-hepatitis C virus drugs: an epidemiologic surveillance study of the FDA adverse event reporting system (FAERS). Clin Endocrinol. 2021. https:\/\/doi.org\/10.1111\/cen.14660.","journal-title":"Clin Endocrinol"},{"key":"1210_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab347","author":"Y Noguchi","year":"2021","unstructured":"Noguchi Y, Tachi T, Teramachi H. Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Brief Bioinform. 2021. https:\/\/doi.org\/10.1093\/bib\/bbab347.","journal-title":"Brief Bioinform"},{"key":"1210_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jclinepi.2021.01.015","volume":"134","author":"C Khouri","year":"2021","unstructured":"Khouri C, Petit C, Tod M, Lepelley M, Revol B, Roustit M, et al. Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases. J Clin Epidemiol. 2021;134:14\u201321. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.01.015.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"1210_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/apt.12385","volume":"38","author":"P Deepak","year":"2013","unstructured":"Deepak P, Stobaugh DJ, Sherid M, Sifuentes H, Ehrenpreis ED. Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System. Aliment Pharmacol Ther. 2013;38(4):388\u201396. https:\/\/doi.org\/10.1111\/apt.12385.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"1210_CR23","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/rheumatology\/keu145","volume":"53","author":"J B\u00e9n\u00e9","year":"2014","unstructured":"B\u00e9n\u00e9 J, Moulis G, Auffret M, Lefevre G, Coquerelle P, Coupe P, et al. Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database. Rheumatology (Oxford). 2014;53(8):1465\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/keu145.","journal-title":"Rheumatology (Oxford)"},{"issue":"Pt A","key":"1210_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107049","volume":"89","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Yue QY. Tumor necrosis factor inhibitor-induced pleuropericarditis: a retrospective evaluation using data from VigiBase. Int Immunopharmacol. 2020;89(Pt A): 107049. https:\/\/doi.org\/10.1016\/j.intimp.2020.107049.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1210_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102460","volume":"19","author":"O Vollmer","year":"2020","unstructured":"Vollmer O, Felten R, Mertz P, Lebrun-Vignes B, Salem JE, Arnaud L. Characterization of auto-immune hepatitis associated with the use of anti-TNF\u03b1 agents: an analysis of 389 cases in VigiBase. Autoimmun Rev. 2020;19(3): 102460. https:\/\/doi.org\/10.1016\/j.autrev.2020.102460.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"1210_CR26","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1080\/14712598.2021.1948529","volume":"21","author":"F Mazhar","year":"2021","unstructured":"Mazhar F, Battini V, Gringeri M, Pozzi M, Mosini G, Marran AMN, et al. The impact of anti-TNF\u03b1 agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database. Expert Opin Biol Ther. 2021;21(9):1281\u201390. https:\/\/doi.org\/10.1080\/14712598.2021.1948529.","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"1210_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11892-016-0792-9","volume":"16","author":"SJ Pilla","year":"2016","unstructured":"Pilla SJ, Quan AQ, Germain-Lee EL, Hellmann DB, Mathioudakis NN. Immune-modulating therapy for rheumatologic disease: implications for patients with diabetes. Curr DiabRep. 2016;16(10):91. https:\/\/doi.org\/10.1007\/s11892-016-0792-9.","journal-title":"Curr DiabRep"},{"issue":"2\u20133","key":"1210_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1385\/endo:23:2-3:177","volume":"23","author":"SE Borst","year":"2004","unstructured":"Borst SE. The role of TNF-alpha in insulin resistance. Endocrine. 2004;23(2\u20133):177\u201382. https:\/\/doi.org\/10.1385\/endo:23:2-3:177.","journal-title":"Endocrine"},{"issue":"D1","key":"1210_CR29","doi-asserted-by":"publisher","first-page":"D1200","DOI":"10.1093\/nar\/gkab880","volume":"50","author":"G Xiong","year":"2022","unstructured":"Xiong G, Yang Z, Yi J, Wang N, Wang L, Zhu H, et al. DDInter: an online drug-drug interaction database towards improving clinical decision-making and patient safety. Nucleic Acids Res. 2022;50(D1):D1200\u20137. https:\/\/doi.org\/10.1093\/nar\/gkab880.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1210_CR30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/00325481.2021.1889820","volume":"133","author":"N Imanova Yaghji","year":"2021","unstructured":"Imanova Yaghji N, Kan EK, Akcan S, Colak R, Atmaca A. Hydroxychloroquine sulfate related hypoglycemia in a non-diabetic COV\u0130D-19 patient: a case report and literature review. Postgrad Med. 2021;133(5):548\u201351. https:\/\/doi.org\/10.1080\/00325481.2021.1889820.","journal-title":"Postgrad Med"},{"issue":"5","key":"1210_CR31","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.dsx.2020.07.003","volume":"14","author":"K Shah","year":"2020","unstructured":"Shah K, Tiwaskar M, Chawla P, Kale M, Deshmane R, Sowani A. Hypoglycemia at the time of Covid-19 pandemic. Diabetes Metab Syndr. 2020;14(5):1143\u20136. https:\/\/doi.org\/10.1016\/j.dsx.2020.07.003.","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"1210_CR32","doi-asserted-by":"publisher","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","volume":"152","author":"AB Goldfine","year":"2010","unstructured":"Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med. 2010;152(6):346\u201357. https:\/\/doi.org\/10.7326\/0003-4819-152-6-201003160-00004.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1210_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.numecd.2018.02.014","volume":"28","author":"E Raschi","year":"2018","unstructured":"Raschi E, Poluzzi E, Salvo F, Pariente A, De Ponti F, Marchesini G, et al. Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems. Nutr Metab Cardiovasc Dis. 2018;28(6):533\u201342. https:\/\/doi.org\/10.1016\/j.numecd.2018.02.014.","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01210-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-022-01210-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01210-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T10:09:15Z","timestamp":1661335755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-022-01210-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1210"],"URL":"https:\/\/doi.org\/10.1007\/s40264-022-01210-2","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"29 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by the National Natural Science Foundation of China (No. 82100872), the High-level Personnel Research Start-up Funding of Fujian Medical University (No. XRCZX2020003), the Scientific Research Project of Fujian Education Department (No. JAT190175), the Joint Funds for Innovation of Science and Technology of Fujian province (No. 2019Y9062) and the Natural Science Foundation of Fujian Province (No. 2020J011012).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"No conflicts of interest, financial or otherwise, are declared by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agreed with the publication of study\u2019s results.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Publicly available datasets were analyzed in this study. This data can be found here: .","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"YZ, SJZ and LJW were responsible for study design, data acquisition and interpretation, statistical analysis, and writing and editing of the manuscript. WHX, LYW, XYZ, JBL and LBL, aided in data acquisition and interpretation and statistical analysis. All authors read and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}